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Abstract
In the elderly, many alterations of both innate and clonotypic immunity have been described.
Alterations to the immune system in the elderly are generally viewed as a deterioration of
immunity, leading to the use of the term immunosenescence. However, although many
immunological parameters are often notably reduced in the elderly, retained function of both innate
and clonotypic immunity in the elderly is tightly correlated to health status. Recognising the
important role of the immune system in ageing, over the last few years, journals oriented towards
gerontology and geriatric sciences have increasingly published articles dealing with the immunology
of ageing, but a specialised journal in this area does not exist. Immunity & Ageing is a new Open
Access, peer reviewed journal that aims to cover all the topics dealing with innate and clonotypic
immunity which are relevant to ageing. The journal will provide an opportunity to focus on this
topic, which is emerging as one of the critical mechanisms of ageing. Furthermore, as an online,
Open Access journal, Immunity & Ageing will promote immediate accessibility to research, which is
generally not possible for articles published in printed journals. We hope this forum, concentrating
on the themes of ageing and immunology with a strong focus on human studies, will create a new
perspective for viewing a world that is inevitably becoming older.
Immunity & Ageing is a new Open Access, peer reviewed
journal that aims to provide a forum for articles examin-
ing ageing from an immunological point of view.
During the past century, humans have gained more years
of average life expectancy than in the last 10,000 years; we
are now living in a rapidly ageing world. The sharp rise in
life expectancy, coupled to a steady decline in birth rates
in all developed countries, has led to an unprecedented
demographic revolution characterized by an explosive
growth in the number and proportion of older people.
The number of people aged 60 years or older exceeded
635 million in 2002, and is expected to grow to nearly 2
billion by 2050. The proportion of people aged 60 and
over stands about 1 in 4 in many Western European coun-
tries as well as in Japan. Should the present trend contin-
ues, this ratio is expected to reach 1 in 3 by 2050 [1].
Among the aged, the oldest old (>85) make up the fastest
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growing category. As access to medical care improves
worldwide, the rate of population ageing will accelerate. If
global communications is making the world "young and
fast", then global ageing is surely "maturing and slowing"
it. In any case, these epidemiological facts underscore the
importance of studies on successful and unsuccessful age-
ing and necessitate the prompt spread of knowledge
about ageing in order to satisfactorily decrease the medi-
cal, economic and social problems associated with
advancing years.
Ageing
Ageing is a post-maturational process that, due to a dimin-
ished homeostatic capacity and increased vulnerability,
reduces responsiveness to environmental stimuli and is
generally associated with an increased predisposition to
illness and death. At the beginning of the 19th century,
mortality was described as increasing exponentially with
respect to progression through the lifespan [2]. This trend,
also described in invertebrates, persists: in Western coun-
tries the mortality rate increases 25 times more rapidly in
individuals over 60 years old compared to people aged
25–44. Causes of death in aged people are increased com-
pared with individuals between 25 and 44 years old: can-
cer 43-fold, pneumonia and influenza 89-fold, heart
disease 92-fold and stroke and chronic lung disease
greater than 100-fold [3]. Thus far, to understand ageing
mechanisms, much attention has been paid to gene muta-
tions in invertebrates and caloric restriction in rodents.
However, these data suggest a key role for immunity in the
survival of the elderly because susceptibility to these dis-
eases depends at least in part on optimal immune func-
tion [4,5]. So, a better understanding of the ageing
immune system may provide the most important clues for
slowing the inevitable decline associated with the passage
of time.
Immunity in ageing
In the elderly, many alterations in innate and clonotypic
immunity have been described and viewed as deleterious,
hence the term immunosenescence. In 1969, Roy Walford
published his landmark book, "The Immunologic Theory
of Aging", and first coined the term immunosenescence
[6]. Significantly, most of the areas that he pioneered dur-
ing his illustrious research career remain the "hot" areas of
current gerontological research. On the other hand,
immunosenescence is a complex process involving multi-
ple reorganizational and developmentally regulated
changes, rather than simple unidirectional decline of the
whole function [7,8]. However, some immunological
parameters are commonly notably reduced in the elderly
and, reciprocally good function is tightly correlated to
health status [4,5].
Innate immunity in ageing
The process of maintaining life for the individual is a con-
stant struggle to preserve his/her integrity. This can come
at a price when immunity is involved, namely systemic
inflammation [9]. Inflammation is not a negative phe-
nomenon per se: it is the response of the immune system
to the invasion of viruses or bacteria and other pathogens.
The problem is that in the course of evolution the human
organism was set to live 40 or 50 years. Today, however,
the immune system must remain active for longer. This
very long activity leads to a chronic inflammation that
slowly but inexorably damages all the organs: this is the
typical phenomenon linked to ageing and it is considered
the major risk factor for age-related chronic diseases, such
as osteoporosis, sarcopenia, type 2 diabetes, Alzheimer's
disease and atherosclerosis, though progression seems
also dependent on the genetic background of individuals
[4,5,8,10,11]. Emerging evidence suggests that pro-
inflammatory genotypes are related to unsuccessful age-
ing, and, reciprocally, controlling inflammatory status
may allow a better chance of successful ageing [4,5,8,12].
In other words, age-related diseases are "the price we pay"
for an active immune system that defends us thorough out
life, but also has the capacity to harm us later, as its fine
tuning becomes compromised [13]. In fact, our immune
system has evolved to control pathogens, so pro-inflam-
matory responses are likely to be evolutionarily pro-
grammed to resist fatal infections with an increased
resistance to pathogens. Thus, inflammatory genotypes
are an important and necessary part of the normal host
responses to pathogens in early life, but the overproduc-
tion of inflammatory molecules might also cause
immune-related inflammatory diseases and eventually
death later. Therefore, low responder genotypes might
better control inflammatory responses and age-related
disease development, resulting in an increased chance of
long life survival in a facilitory environment with reduced
pathogen load and medical care, such as might be present
in Western societies [12,14-16].
Clonotypic immunity in ageing
Recently, longitudinal studies have shown that a cluster of
immunological parameters can be used to evaluate the
expectation and quality of life, i.e. the immunological risk
phenotype [17,18]. Senescence of clonotypic immunity is
most likely principally a result of alterations to T cells.
Lifelong and chronic antigen load seems to be the major
driving force of immunosenescence, which impacts on
human lifespan by reducing the number of virgin antigen-
non experienced T cells, and, simultaneously, fills the
immunological space with expanded clones of memory
and effector, antigen-experienced T cells [18-20]. Gradu-
ally, the T cell population shifts to a lower ratio of naïve
cells to memory cells, the thymus pumps out fewer naïve
T cells with age and those T cells remaining, especially theImmunity & Ageing 2004, 1:1 http://www.immunityageing.com/content/1/1/1
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CD8+ subset, also show increased oligloclonality with age
[4]. Thus, the repertoire of cells available to respond to
antigenic challenge from previously unencountered path-
ogens is reduced. In addition, older organisms are often
overrun by memory cells that carry a single type of T cell
repertoire, i.e. clonal expansion. Thus, the memory cells
from old individuals might recognize a limited set of anti-
gens despite being plentiful in number. Many of the
clonal expansions crowding an elderly person's immune
system result from previous infections by persisting
viruses [18,19].
In contrast to T cells, no evidence for a loss of B cell func-
tion has been found as neither the total number of B cells
or immunoglobulin secreting cells have been shown to be
profoundly decreased with age. However, the B-cell reper-
toire is influenced by ageing during an actual immune
response, where the spectrum of expressed immunoglob-
ulin genes, as well as the frequency of somatic mutations,
affects the quality, though not necessarily the quantity, of
the antibody response, which is highly relevant in clinical
practice [7,21].
Immunity & Ageing. Why do we need an Open 
Access journal?
Considering the paramount function of the immune sys-
tem during ageing, journals oriented towards gerontology
and geriatric sciences are now publishing an increasing
number of articles dealing with immunology and ageing,
but a specialised journal in this area does not exist. Immu-
nity & Ageing was conceived to cover all topics relevant to
immunity and ageing in an interdisciplinary manner. It is
clear that immunological mechanisms are involved in
process and manifestation of ageing in many systems. An
example is displayed by the increase in serum and tissue
levels of circulation pro-inflammatory cytokines which is
accompanied by typical cellular ageing phenomena such
as telomeric loss, oxidative damage, DNA defects, accu-
mulation of advanced glycosylation products, cellular loss
and others. These defects may be stimulators of cytokine
secretion, and subsequently, cytokines are released into
the systemic circulation. This results in a slowly progres-
sive endo-crinosenescence and neurosenescence. The dif-
ferent factors may influence each other in form of a
vicious spiral [22].
The journal will provide an opportunity to focus the topic
of immunology of ageing, which is emerging as one of the
critical mechanisms of ageing which aspects should get to
all scientists physicians and other professions who are
involved in the different inter-related disciplines, and the
bridge that is emerging between these fields.
Furthermore, as an online, Open Access journal, Immunity
& Ageing will promote "immediate" accessibility to this
fast moving area of research, which is generally not possi-
ble for articles published in printed journals. From a mod-
ern perspective, electronic publishing is obviously
attractive for its speed, easy global access and low cost,
which all present considerable advantages over print and
are seen as attractive factors by authors, readers and pub-
lishers. Open Access appears to provide exactly what peo-
ple would like: rapid publication for authors, free access
to information for readers, and inexpensive, global avail-
ability to readers for publishers [23]. We believe knowl-
edge should belong to those who want it and access
should not be unjustly and unacceptably expensive or dif-
ficult. Immunity & Ageing will take advantage of the Open
Access policy to make peer-reviewed information widely
and almost immediately available. We hope this forum,
focussing on the themes of ageing and immunology, will
create a new perspective for looking at a world that is inev-
itably becoming older. Creating and pushing forward a
research knowledge base in Immunity & Ageing provides a
unique opportunity to dissect out some parameters which
might make health span equate with increasing lifespan.
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